Acute Kidney Injury in Patients Receiving Anti-Tuberculosis Treatment

लेखक

  • Madiha Mehmood Department of Nephrology, King Edward Medical Universiy, Lahore, Pakistan
  • Muhammad Anees Department of Nephrology, King Edward Medical Universiy, Lahore, Pakistan

##semicolon##

https://doi.org/10.53778/pjkd92302

##semicolon##

acute kidney injury##common.commaListSeparator## anti tuberculous treatment##common.commaListSeparator## ATT##common.commaListSeparator## Rifampicin##common.commaListSeparator## Isoniazid##common.commaListSeparator## AKI

सार

Although life-saving, anti-tuberculosis therapy (ATT) carries the risk of acute kidney injury (AKI), potentially complicating its management.

 

Methods: 102 subjects starting on ATT were followed for 2 months. Presence of AKI was documented with monitoring of kidney functions.

Results:

AKI was observed among 14.7% patients, predominantly affecting middle-aged males.

Conclusion:

Early recognition of AKI by monitoring for kidney function is crucial for reducing the risk of long-term sequelae of kidney failure among patients taking ATT.

PJKD

##submission.downloads##

प्रकाशित

2025-06-30

अंक

खंड 9 No. 2 (2025): Pakistan Journal of Kidney Diseases

खंड

Original Article

##submission.license##

##submission.copyrightStatement##

##submission.license.cc.by-nc4.footer##

##submission.howToCite##

Acute Kidney Injury in Patients Receiving Anti-Tuberculosis Treatment. (2025). Pakistan Journal of Kidney Diseases, 9(2), 16-19. https://doi.org/10.53778/pjkd92302